T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Tesla
TSLA
|
+$1.87B |
| 2 |
T-Mobile US
TMUS
|
+$1.53B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.43B |
| 4 |
Apple
AAPL
|
+$1.28B |
| 5 |
PepsiCo
PEP
|
+$1.1B |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.16B |
| 2 |
Amazon
AMZN
|
+$3.02B |
| 3 |
GE Aerospace
GE
|
+$2.2B |
| 4 |
Goldman Sachs
GS
|
+$1.76B |
| 5 |
Salesforce
CRM
|
+$1.43B |
Sector Composition
| 1 | Technology | 30.27% |
| 2 | Healthcare | 17.75% |
| 3 | Financials | 11.3% |
| 4 | Consumer Discretionary | 11.17% |
| 5 | Communication Services | 8.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
926
Rollins
ROL
$27.3B
| $19.3M | ﹤0.01% |
513,354
+4,893
| +1% | +$184K |
|
927
Pultegroup
PHM
$26.7B
| $19.2M | ﹤0.01% |
329,246
-11,528
| -3% | -$672K |
|
928
Henry Schein
HSIC
$8.43B
| $19.2M | ﹤0.01% |
235,255
-28,001
| -11% | -$2.28M |
|
929
Clearway Energy Class C
CWEN
$3.35B
| $19.1M | ﹤0.01% |
608,241
-92,439
| -13% | -$2.9M |
|
930
iShares Core MSCI EAFE ETF
IEFA
$153B
| $18.9M | ﹤0.01% |
283,362
-72,117
| -20% | -$4.82M |
|
|
AJRD
931
DELISTED
Aerojet Rocketdyne Holdings, Inc.
AJRD
| $18.9M | ﹤0.01% |
336,418
-365,736
| -52% | -$20.5M |
|
|
NVEE
932
DELISTED
NV5 Global
NVEE
| $18.9M | ﹤0.01% |
726,564
+28,044
| +4% | +$729K |
|
|
AIRC
933
DELISTED
Apartment Income REIT Corp.
AIRC
| $18.8M | ﹤0.01% |
525,991
-528,929
| -50% | -$18.9M |
|
934
Structure Therapeutics
GPCR
$1.2B
| $18.7M | ﹤0.01% |
+786,505
| New | +$18.7M |
|
935
Ziff Davis
ZD
$1.5B
| $18.6M | ﹤0.01% |
238,379
-26,790
| -10% | -$2.09M |
|
936
Supernus Pharmaceuticals
SUPN
$2.59B
| $18.5M | ﹤0.01% |
509,972
+619
| +0.1% | +$22.4K |
|
|
AMED
937
DELISTED
Amedisys
AMED
| $18.4M | ﹤0.01% |
250,163
-22,766
| -8% | -$1.67M |
|
938
NetApp
NTAP
$25B
| $18.4M | ﹤0.01% |
287,446
+4,388
| +2% | +$280K |
|
939
DraftKings
DKNG
$22.8B
| $18.3M | ﹤0.01% |
947,598
+128,288
| +16% | +$2.48M |
|
940
AtriCure
ATRC
$1.75B
| $18.1M | ﹤0.01% |
435,450
+819
| +0.2% | +$33.9K |
|
941
Nordson
NDSN
$12.6B
| $18M | ﹤0.01% |
81,099
+2,593
| +3% | +$576K |
|
942
Grab
GRAB
$22.5B
| $17.9M | ﹤0.01% |
5,946,137
-3,764,711
| -39% | -$11.3M |
|
943
Alliant Energy
LNT
$16.4B
| $17.9M | ﹤0.01% |
334,709
+6,651
| +2% | +$355K |
|
944
MoonLake Immunotherapeutics
MLTX
$3.45B
| $17.8M | ﹤0.01% |
830,906
+8,305
| +1% | +$178K |
|
945
Snap-on
SNA
$16.9B
| $17.7M | ﹤0.01% |
71,860
+1,829
| +3% | +$452K |
|
946
Amphastar Pharmaceuticals
AMPH
$1.32B
| $17.6M | ﹤0.01% |
468,420
-320,750
| -41% | -$12M |
|
947
ASGN Inc
ASGN
$2.23B
| $17.5M | ﹤0.01% |
211,718
-48,390
| -19% | -$4M |
|
948
DoubleVerify
DV
$2.26B
| $17.5M | ﹤0.01% |
579,166
+38,923
| +7% | +$1.17M |
|
949
Williams-Sonoma
WSM
$24.7B
| $17.5M | ﹤0.01% |
287,056
-23,116
| -7% | -$1.41M |
|
950
Akamai
AKAM
$11B
| $17.4M | ﹤0.01% |
222,060
+14,565
| +7% | +$1.14M |
|